Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study☆

[1]  S. Ansell.  Non-Hodgkin Lymphoma: Diagnosis and Treatment. , 2015, Mayo Clinic proceedings.

[2]  B. Nathwani,et al.  Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. , 2011, Blood.

[3]  S. Pileri,et al.  Enteropathy-associated T-cell lymphoma. , 2011, Critical reviews in oncology/hematology.

[4]  S. Proctor,et al.  Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. , 2010, Blood.

[5]  B. Rini.  Metastatic renal cell carcinoma: many treatment options, one patient. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Amiot,et al.  Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. , 2009, Gastroenterology.

[7]  Tsung-Teh Wu,et al.  Clinical staging and survival in refractory celiac disease: a single center experience. , 2009, Gastroenterology.

[8]  J. Cerhan,et al.  Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. , 2008, Blood.

[9]  R. Gascoyne,et al.  Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. , 2007, Gastroenterology.

[10]  W. Verbeek,et al.  Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience , 2007, Gut.

[11]  S. Novaković,et al.  A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas. , 2006, Oncology reports.

[12]  K. Musshoff,et al.  Prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification , 1975, Zeitschrift für Krebsforschung und Klinische Onkologie.

[13]  E. Thiel,et al.  Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Macintyre,et al.  Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. , 2003, Gastroenterology.

[15]  A. Chott,et al.  18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma , 2003, Gut.

[16]  E. Macintyre,et al.  Refractory coeliac sprue is a diffuse gastrointestinal disease , 2003, Gut.

[17]  F. Goldwasser,et al.  Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  B. Vekic,et al.  [Primary lymphoma of the small intestine]. , 2003, Medicinski pregled.

[19]  E. Trimble,et al.  Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  E. Macintyre,et al.  Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma , 2000, The Lancet.

[21]  D. Wright,et al.  Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  N. Brousse,et al.  Push enteroscopy in celiac sprue and refractory sprue. , 1999, Gastrointestinal endoscopy.

[23]  G. Oberhuber,et al.  The histopathology of coeliac disease: time for a standardized report scheme for pathologists. , 1999, European journal of gastroenterology & hepatology.

[24]  A. Chott,et al.  Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. , 1998, The American journal of pathology.

[25]  E. Macintyre,et al.  Abnormal intestinal intraepithelial lymphocytes in refractory sprue. , 1998, Gastroenterology.

[26]  D. Wright.  Enteropathy associated T cell lymphoma. , 2021, Cancer surveys.

[27]  A. Fischer,et al.  Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. , 1996, Pediatrics.

[28]  S. Walsh,et al.  Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. , 1995, Journal of clinical gastroenterology.

[29]  D. Rimm,et al.  Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin , 1994, Nature.

[30]  D. Rimm,et al.  Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. , 1994, Nature.

[31]  A. Norton,et al.  Primary Lymphoma of the Small Intestine A. Clinicopathological Study of 119 Cases , 1993, The American journal of surgical pathology.

[32]  F. Deist,et al.  Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. , 1993, Gut.

[33]  A. Chott,et al.  Peripheral T-cell lymphomas of the intestine. , 1992, The American journal of pathology.

[34]  N. Cerf-Bensussan,et al.  The human intraepithelial lymphocyte marker HML‐1 is an integrin consisting of a β7 subunit associated with a distinctive α chain , 1992 .

[35]  M N Marsh,et al.  Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). , 1992, Gastroenterology.

[36]  N. Cerf-Bensussan,et al.  The human intraepithelial lymphocyte marker HML-1 is an integrin consisting of a beta 7 subunit associated with a distinctive alpha chain. , 1992, European journal of immunology.

[37]  D. Wingate.  Surgery of the liver , 1990 .

[38]  P. Isaacson,et al.  Do vascular addressins mediate tissue specific lymphocyte extravasation? , 1988, The Journal of pathology.

[39]  N. Brousse,et al.  Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. , 1988, The American journal of pathology.